Skip to content
Recall Observatory FDA recall evidence

Drug product

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

D-0616-2018

March 21, 2018

Class III

Product summary

Firm
Mayne Pharma Inc
Event
Event 79604
Status
Terminated
Classification
Class III
Quantity
3312 cans
Official record key
drug-enforcement:D-0616-2018

Official wording

Reason: Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.

Code information: Lot: MBEB, Exp. 01/31/2019

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent